2026. Differential Cardiometabolic Effects of GLP-1 Receptor Agonists Versus SGLT2 Inhibitors in Early-Onset Type 2 Diabetes: A Randomized Controlled Trial. Link Medical Journal. 4, 1 (Jun. 2026), 1–9. DOI:https://doi.org/10.61919/061x6w21.